Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3985676
Max Phase: Preclinical
Molecular Formula: C48H51ClN6O6S2
Molecular Weight: 907.56
Molecule Type: Small molecule
Associated Items:
ID: ALA3985676
Max Phase: Preclinical
Molecular Formula: C48H51ClN6O6S2
Molecular Weight: 907.56
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4cnc(OCC5CCOCC5)c(-c5nccs5)c4)c(Oc4ccc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1
Standard InChI: InChI=1S/C48H51ClN6O6S2/c1-48(2)15-11-35(42(28-48)33-3-5-36(49)6-4-33)30-54-18-20-55(21-19-54)37-7-9-40(44(26-37)61-38-8-10-43-34(25-38)12-16-50-43)45(56)53-63(57,58)39-27-41(47-51-17-24-62-47)46(52-29-39)60-31-32-13-22-59-23-14-32/h3-10,12,16-17,24-27,29,32,50H,11,13-15,18-23,28,30-31H2,1-2H3,(H,53,56)
Standard InChI Key: YDPGMDBSEGKBIR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 907.56 | Molecular Weight (Monoisotopic): 906.3000 | AlogP: 9.84 | #Rotatable Bonds: 13 |
Polar Surface Area: 138.98 | Molecular Species: ACID | HBA: 11 | HBD: 2 |
#RO5 Violations: 3 | HBA (Lipinski): 12 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.13 | CX Basic pKa: 7.96 | CX LogP: 7.45 | CX LogD: 7.57 |
Aromatic Rings: 6 | Heavy Atoms: 63 | QED Weighted: 0.12 | Np Likeness Score: -0.97 |
1. (2015) Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases, |
Source(1):